SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0000950123-10-048432
Filing Date
2010-05-12
Accepted
2010-05-12 15:55:13
Documents
1
Period of Report
2010-03-31
Effectiveness Date
2010-05-12

Document Format Files

Seq Description Document Type Size
1 NOTICE UNDER RULE 12B-25 c00547nt10vq.htm NT 10-Q 24498
  Complete submission text file 0000950123-10-048432.txt   25964
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 10824420
SIC: 2836 Biological Products, (No Diagnostic Substances)